Health-related Physical Fitness in Patients with Inflammatory Bowel Disease

NCT ID: NCT05482932

Last Updated: 2024-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-17

Study Completion Date

2024-09-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Rationale: Existing literature suggests an impaired health-related physical fitness (HRPF) (i.e., body composition, aerobic capacity, muscular strength, muscular endurance, and flexibility) in patients with inflammatory bowel disease (IBD). However, previous studies did not assess HRPF with the 5- component multidimensional concept. HRPF is not routinely screened for and measured within the IBD population in clinical practice. The lack of a simple screening tool and assessment method for HRPF validated for the IBD population hinders the ability to distinguish patients with IBD with adequate physical fitness from those who might benefit from physical exercise interventions targeting specific components. Gold standard measures are too expensive and too complex to implement in daily practice and therefore a screening tool and a simpler assessment battery for HRPF validated in patients with IBD are needed. It is necessary to obtain more objective insights into the specific components of HRPF affected in patients with IBD, and its association with patient-, disease-, and treatment-related factors in order to implement systematic screening in routine care and subsequently offer tailored physical exercise interventions.

Objective: The main objective of this study is to validate a simple screening tool and a best-practice assessment battery for the different components of HRPF against gold standard measures. Secondary objectives are to objectively assess the incidence of specific components affected in patients with IBD compared to healthy control subjects and to explore the association between these components of HRPF affected and patient-, disease-, and treatment-related factors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study involves one or two study visits for patients with IBD and only one study visit for healthy volunteers. During the first study visit, all participants (n=200) will perform the tests of the assessment battery for HRPF and complete several questionnaires. A representative subgroup of patients with IBD will undergo the gold standard measurements for HRPF during a second study visit. Furthermore, total physical activity measured by accelerometry will be measured in this subgroup of patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Diseases Ulcerative Colitis Crohn Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Inflammatory bowel disease Ulcerative Colitis Crohn Disease Health-related physical fitness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with IBD

100 patients with IBD; either Ulcerative Colitis (N=50) or Crohns disease (N=50)

Health-related physical fitness assessment

Intervention Type DIAGNOSTIC_TEST

Participants will complete several questionnaires and perform multiple health-related physical fitness tests

Healthy volunteers without IBD

100 healthy volunteers (without IBD)

Health-related physical fitness assessment

Intervention Type DIAGNOSTIC_TEST

Participants will complete several questionnaires and perform multiple health-related physical fitness tests

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Health-related physical fitness assessment

Participants will complete several questionnaires and perform multiple health-related physical fitness tests

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any gender aged 18 years or older;
* American Society of Anesthesiologists (ASA) Physical Status I or II (i.e., normal healthy patient or a patient with mild systemic disease)
* No contraindications for exercise testing based on the PAR-Q
* Being able to provide written informed consent;
* Willing and able to complete questionnaires and perform performance tests;
* Being able to understand written Dutch and speak the Dutch language.


* Certified diagnosis of IBD (UC or CD) based on the combination of endoscopic, radiological, and/or histological findings;
* No active disease or experiencing mild to moderate disease activity.
* Included in eHealth clinical care-pathway using myIBDcoach.


• No certified diagnosis of IBD (CD, UC, IBD-Unclassified);

Exclusion Criteria

* ASA Physical Status \> II (i.e., patient with severe systemic disease);
* Contraindications for exercise testing based on PAR-Q
* Other (temporary) injuries or severe (neuro)muscular, rheumatic, or orthopedic conditions that may interfere with study evaluations;
* Current malignancy (except for local cutaneous skin cancer) or successfully treated for a malignancy in the past 6 months;
* Pregnant or lactating women;
* Competitive and elite athletes (i.e., ≥6 hours/week of moderate to vigorous exercise)
* Not being able to understand or speak the Dutch language;
* Not being able to cooperate with test procedures or unable to provide informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dutch Gastroenterology & Hepatology Foundation (Maag Lever Darm Stichting)

UNKNOWN

Sponsor Role collaborator

Maastricht University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

M.J. Pierik, Prof.

Role: PRINCIPAL_INVESTIGATOR

Maastricht University Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maastricht University Medical Center +

Maastricht, Limburg, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ZP 21-13

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

NL79305.068.22

Identifier Type: -

Identifier Source: org_study_id